ZEVEX Announces Marketing Alliance with Option Care

ZEVEX International Inc. (NASDAQ: ZVXI), a manufacturer
and marketer of design award-winning enteral feeding pumps, and Option
Care Inc., a leading provider of home care and infusion services,
announced the commencement of a formal sales and marketing alliance
for ZEVEX's EnteraLite(R) Infinity(TM) enteral feeding pump. Under the
terms of the alliance, Option Care has become a non-exclusive
distributor of EnteraLite Infinity enteral feeding pumps to Option
Care's consumer patient population through its national network of 130
company-owned and franchise locations in 32 states.
   David McNally, CEO and president of ZEVEX, said, "This is an
exceptional opportunity for Option Care and ZEVEX to cooperatively
expand the number of enteral patients that can experience the health
and quality of life benefits of ambulatory pump technology. The
portability, durability and accuracy of the EnteraLite Infinity allow
Option Care to market to a broad customer base in home healthcare and
alternate site facilities. We are very pleased that Option Care has
selected the EnteraLite Infinity as the pump technology of choice for
its new enteral nutrition therapy program. Option Care's national
reputation, dedication to advancing quality of health, and commitment
to nutrition services make them an ideal partner for the expansion of
our Therapeutics business."
   Dan Bramuchi, vice president of sales and operations of Option
Care, said, "The ZEVEX Infinity pump represents leading-edge
technology and Option Care wants to make sure its patients receive the
very best care and equipment. For over 25 years, Option Care has been
providing health care services to patients requiring clinical
nutritional support. As an industry leader in clinical nutrition, we
are excited and pleased to form a marketing alliance with ZEVEX that
will provide benefits to both companies, to health care professionals
and workers, and most importantly to the patients."
   Launched in January of 2005, the EnteraLite Infinity's innovative
technology supports improved patient care through physical, mental and
social health benefits. In 2005 there will be approximately 83,000
patients who will utilize home enteral nutrition therapy, according to
a 2004 report by Medtech Insight. The market for home enteral
nutrition therapy is growing at about four percent per year. By the
end of 2005, the U.S. market value for home enteral nutrition delivery
devices, including pumps and disposables, is expected to reach
approximately $56 million.

   About ZEVEX International Inc.

   ZEVEX International Inc. (www.zevex.com), founded in 1986,
transforms life with its patented and proprietary medical device
technologies. The Therapeutics division manufactures and markets
enteral nutrition delivery devices. The Applied Technology division
designs and manufactures advanced medical components and systems for
medical technology companies.

   About Option Care Inc.

   Option Care provides various home infusion therapies and specialty
injectable pharmaceuticals to patients at home and other alternate
sites such as infusion suites and physician's offices. The company's
services and pharmaceuticals are provided nationally through its local
and regional pharmacies. Further information on Option Care can be
found at: www.optioncare.com.

   Forward-Looking Statements

   Statements made in this press release, including those relating to
anticipated revenue growth and other statements regarding future
performance, are forward looking and are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of
1995. Such statements involve risks and uncertainties that may cause
actual results to differ materially from those set forth in these
statements. Among other things, the company's efforts to increase its
sales could be more difficult or expensive than the company currently
anticipates. Specifically, the marketing alliance between Option Care
and ZEVEX may not produce substantial sales growth. In addition to the
foregoing, the economic, competitive, governmental, technological and
other factors identified in the company's filings with the Securities
and Exchange Commission, including the Form 10-K for the year ended
Dec. 31, 2004, may cause actual results or events to differ materially
from those described in the forward-looking statements in this press
release.